Fast Money's Biotech Takeover Plays
526 views
Rate Now:
average rating: 0.00 / 0 ratings
Created by barrons3
DESCRIPTION:
Date updated:09-30-2009
Investors are placing their bets on the next M&A deal in biotech. Where should you be looking?
-
ALXN
Alexion Pharmaceu - $43.70
- -1.04%
- $43.82
Geoff Porges predicts the next companies to be involved in M&A activity will be in biotech. He zeroes in on names like Alexion (ALXN), Dendreon (DNDN), United Therapeutics (UTHR) and Seattle Generic (SGEN) as potential takeover targets.
-
DNDN
Dendreon Corporat - $28.01
- -0.14%
- $28.51
Geoff Porges predicts the next companies to be involved in M&A activity will be in biotech. He zeroes in on names like Alexion (ALXN), Dendreon (DNDN), United Therapeutics (UTHR) and Seattle Generic (SGEN) as potential takeover targets.
-
UTHR
United Therapeuti - $44.91
- +0.22%
- $44.93
Geoff Porges predicts the next companies to be involved in M&A activity will be in biotech. He zeroes in on names like Alexion (ALXN), Dendreon (DNDN), United Therapeutics (UTHR) and Seattle Generic (SGEN) as potential takeover targets.
-
SGEN
Seattle Genetics - $9.30
- -0.43%
- $9.38
Geoff Porges predicts the next companies to be involved in M&A activity will be in biotech. He zeroes in on names like Alexion (ALXN), Dendreon (DNDN), United Therapeutics (UTHR) and Seattle Generic (SGEN) as potential takeover targets.
-
GILD
Gilead Sciences - $46.39
- -0.28%
- $46.27
Porges is also placing bets on Tamiflu's affect on Gilead (GILD). "People will be stock piling the drug, which will be a boost for Gilead's earnings," he said.
- Top Professional Portfolios
- 1. Fidelity Contrafund - ...
- 2. Navellier & Associ...
- 3. Calamos Advisors
- 4. Argus Management
- 5. Bernard L. Madoff Inve...
- show all
- Top Do-It-Yourself Portfolios
- » Joseph Russell Portfolio 1
- » Albo's First Portfolio
- » Darrell Werth Portfolio 1
- » Echo5Joker's Portfolio
- » jgroov Portfolio 1
- show all
- Most Viewed Portfolios
- » Warren Buffett
- » George Soros
- » T. Boone Pickens - BP Cap...
- » Carl Icahn
- » Renaissance Technologies
- show all
Cramer's Take on Headline Stocks...
Not a Stockpickr member? Join the community today -- for free.Regardless of why a stock is in the news, it never hurts to hear what a professional investor has to say about...
11.20.09 | 11:48 AM
Jim Cramer's Portfolios of the Week
By Roberto Pedone Posted on Nov. 20, 2009 According to Jim Cramer, options expiration is driving the current market selloff. He pointed out that the only stocks that we...
11.20.09 | 08:09 AM
'Fast Money' Portfolios of the Week
By Roberto Pedone Posted on Nov. 19, 2009 According to CNBC’s “Fast Money” traders, the stock market is showing no signs of stopping its current bull run. Joe Ter...
11.19.09 | 11:13 AM
Squeezing the Shorts: Earnings G...
more articles
By Jonas Elmerraji Posted on Nov. 18, 2009 There are plenty of reasons for stocks to have the attention of short-sellers. Waning financials, a deteriorating business mo...
11.18.09 | 12:36 PM
Nymph's Trading Daily Trading Diary
04.13.09 | 01:10 AM From author
Trading Nymph
General market Technical Analysi...
11.14.07 | 22:55 PM From author
ZA
Simple headline speak "1,00...
11.23.09 | 00:02 AM From author
graspthemarket
The Presidential/Political Thread
more forums
01.02.08 | 08:05 AM From author
Dave Cox
Q.
Am I diversified? My major hold...
11.22.09 | 21:36 PM Asked by
fwtrader
A. a sector pair but not an industry pair
AAPL/AMT
Q.
Steel....playing catch up now. ...
03.24.09 | 11:34 AM Asked by
dgbkr
A. The only one I own : SLX,
too hard pick a winner out all of them
today 's lists
52-Week Lows
Here is a list of some of the biggest stocks that hit 52-week lows on Nov. 20, 2009. more
Rising on Unusual Volume
Here are some stocks that moved up on unusual volume on Nov. 19, 2009. more
Analyst Downgrades
Analyst Downgrades or Estimate Reductions for Nov. 20, 2009. Read more here. more
Comments not available